0001759778-18-000001.txt : 20181127 0001759778-18-000001.hdr.sgml : 20181127 20181127151247 ACCESSION NUMBER: 0001759778-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181127 DATE AS OF CHANGE: 20181127 EFFECTIVENESS DATE: 20181127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pattern Pharma Inc. CENTRAL INDEX KEY: 0001759778 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-326610 FILM NUMBER: 181202970 BUSINESS ADDRESS: STREET 1: 31 RIDGE DR. CITY: TORONTO STATE: A6 ZIP: M4T 1B6 BUSINESS PHONE: 416-302-5155 MAIL ADDRESS: STREET 1: 31 RIDGE DR. CITY: TORONTO STATE: A6 ZIP: M4T 1B6 D 1 primary_doc.xml X0708 D LIVE 0001759778 Pattern Pharma Inc. 31 RIDGE DR. TORONTO A6 ONTARIO, CANADA M4T 1B6 416-302-5155 ONTARIO, CANADA None None Corporation true 2018 Mark Frans van Coeverden de Groot 31 Ridge Dr. Toronto A6 ONTARIO, CANADA M4T 1B6 Executive Officer Director Pharmaceuticals No Revenues 06b false 2018-11-12 true true true true true The Special Equity Rights are convertible into shares of the issuer on the 12th of November 2020, or prior to said date on the occurrence of certain events. true 0 40000 40000 0 false 2 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Pattern Pharma Inc. Mark Frans van Coeverden de Gr Mark Frans van Coeverden de Groot President & Chief Executive Officer 2018-11-26